Kim Js

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer

Dongwook Kim, Sun‐Young Kim, H.-K. Kim et al. · Annals of Oncology · 2007 · 355 citations · Full text

Medicine, Oncology, Pharmacology +14

A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

Hongryull Pyo, Hak Choy, George P. Amorino et al. · PubMed · 2001 · 186 citations

Medicine, Oncology, Pharmacology +16

Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung

Kim Js · Carcinogenesis · 2004 · 92 citations

Medicine, Molecular Biology, Oncology +17

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Gunnar Folprecht, Carles Pericay, Mark Saunders et al. · Annals of Oncology · 2016 · 85 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Assessment of safety and drug-induced tumor necrosis with sunitinib in patients (pts) with unresectable hepatocellular carcinoma (HCC)

Sandrine Faivre, Éric Raymond, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 2007 · 72 citations

Medicine, Oncology, Pharmacology +17